Medical Device Tenders in Norway: Manufacturer Bid Guide [2026]

Norway is one of Europe's most prosperous and medically sophisticated markets, with total medical device procurement of approximately NOK 14–17 billion (USD 1.3–1.6 billion) annually. As a European Economic Area (EEA) member, Norway fully applies EU Medical Device Regulation (MDR 2017/745) through the EEA Agreement, meaning CE-marked devices valid in the EU are also valid in Norway without re-registration. For international suppliers, this makes Norway an efficient add-on to an EU market access strategy — with the important caveat that procurement processes, platforms, and local requirements differ significantly from EU member states and require deliberate navigation.

Regulatory authority and approval pathway

The Direktoratet for medisinske produkter (DMP) — the Norwegian Directorate of Medical Products — is the national competent authority for medical devices in Norway. DMP was established in January 2023 when medical device regulation responsibilities were reorganised out of the Norwegian Medicines Agency (Legemiddelverket) into a dedicated directorate (dmp.no).

• Device classification: Norway applies EU MDR risk classification directly — Class I, Class IIa, Class IIb, and Class III. IVDR (2017/746) classification applies to in vitro diagnostic devices on the EU schedule.
• CE marking: Standard EU CE marking under MDR (or valid MDD legacy certificates within applicable transition periods) is directly valid in Norway as an EEA state. No separate Norwegian registration or DMP approval is required for devices that hold valid EU MDR conformity. This is the single most important regulatory advantage of the EEA model for medical device suppliers.
• EUDAMED: Norway participates in EUDAMED (European Database on Medical Devices) under EEA obligations. Economic operators placing devices on the Norwegian market must comply with EUDAMED actor, device, and UDI registration requirements on the same timeline as EU manufacturers. DMP is the Norwegian competent authority in EUDAMED.
• UDI compliance: Unique Device Identification (UDI) obligations under EU MDR apply in Norway on the same schedule as in the EU. UDI-DI registration in EUDAMED is required before commercial placement on the Norwegian market.
• Notified Bodies: DNV AS and FORCE Technology are Norwegian-based EU Notified Bodies designated under EU MDR. Certificates from any EU-designated Notified Body are valid for Norway — suppliers do not need a Norwegian NB certificate specifically.
• Post-market surveillance: Vigilance reporting (serious incidents, field safety corrective actions) is submitted to DMP as the Norwegian competent authority, in parallel with EUDAMED reporting. DMP participates in EU vigilance information exchange through EUDAMED and bilateral competent authority channels.
• Norwegian-language labelling: While CE marking provides market access, product labelling and Instructions for Use (IFU) must be available in Norwegian. English-language labelling is sometimes tolerated for specialist hospital equipment in practice, but Norwegian is required for retail or pharmacy channels and strongly expected in hospital tender compliance documentation packs. German-language IFU is not a substitute.

Key procurement platforms and channels

• Doffin (doffin.no): Norway's national database for public procurement notices, operated by DFØ (Direktoratet for forvaltning og økonomistyring). All public contracts above NOK 100,000 must be notified on Doffin. Contracts above the EU threshold (approximately NOK 1.84 million for goods and services, adjusted for currency) must also be published on TED. Doffin is the authoritative starting point for any systematic tender monitoring of Norwegian public hospital procurement and includes both prior information notices (planning) and contract notices (active tenders).
• Sykehusinnkjøp HF: The national hospital procurement company, wholly owned by the four Regional Health Authorities (RHF). Sykehusinnkjøp HF is the most significant purchasing organisation for medical devices in the Norwegian public health sector. It conducts national competitive tenders and establishes multi-year framework agreements (rammeavtaler) that the four RHFs and their hospital trusts use to procure devices without running individual tenders each time. For most medical device categories, admission to a Sykehusinnkjøp HF framework agreement is the gateway to the entire Norwegian public specialist hospital market. Framework tender notices are published on Doffin.
• Regional Health Authorities (RHF): Norway's specialist healthcare is organised into four RHFs — Helse Sør-Øst (South-East, the largest, covering Oslo and the surrounding region), Helse Vest (West, including Bergen), Helse Midt-Norge (Central Norway, including Trondheim), and Helse Nord (North, including Tromsø). Each RHF owns a group of hospital trusts (HF). While Sykehusinnkjøp HF manages national framework agreements, individual RHFs and hospital trusts also conduct regional tenders for specialised requirements not covered by national frameworks.
• Hospital trust direct procurement: Major hospital trusts — Oslo University Hospital (OUS/Rikshospitalet), Haukeland University Hospital (Bergen), St. Olavs Hospital (Trondheim), and the University Hospital of North Norway (UNN, Tromsø) — conduct direct procurement for high-value or specialised equipment not covered by existing framework agreements. These tenders appear on Doffin.
• Municipal healthcare procurement: Norwegian municipalities (kommuner) fund primary healthcare including nursing homes, GP practices, and rehabilitation facilities. Municipal procurement is published on Doffin and operates through individual municipal procurement units. This channel is distinct from the RHF specialist healthcare system and growing in relevance as Norway shifts care toward community settings.

Compliance requirements for public tenders

• Valid CE marking under MDR: The fundamental eligibility requirement. CE marking must be current; expired certificates disqualify submissions even if renewal is in process. EUDAMED registration confirmation is increasingly included in Sykehusinnkjøp HF technical qualification requirements.
• ISO 13485:2016: Quality management system certification is universally expected in Norwegian hospital tender technical documentation for Class IIa and above devices. Some Class I device tenders also request QMS certificates.
• Norwegian-language submissions: Sykehusinnkjøp HF tenders explicitly require Norwegian-language tender responses and technical documentation. Bilingual Norwegian-English documentation is generally acceptable; English-only submissions may be disqualified at the qualification stage.
• Tax and registry compliance: Norwegian public procurement law requires bidders to confirm compliance with Norwegian tax obligations. Foreign companies operating in Norway may need to obtain a Norwegian organisational number (organisasjonsnummer) from the Brønnøysund Register Centre, particularly for VAT registration purposes.
• HMS (helse, miljø, sikkerhet) declaration: Norwegian tenders require a signed HMS self-declaration confirming compliance with the Norwegian Working Environment Act (Arbeidsmiljøloven) and associated health, safety, and environment regulations.
• Reference installations: Norwegian hospital procurement requires documented reference installations at comparable hospitals, typically with named contact persons for verification. Anonymous or generic references are rarely accepted. Norwegian or Scandinavian reference sites carry greater weight than non-Nordic references for most evaluation committees.
• Service capacity within Norway: Sykehusinnkjøp HF framework tenders consistently require evidence of service and support capacity within Norway, including response time commitments for critical equipment (typically 4–8 hours for clinical critical devices). Remote service routed exclusively from other European countries is a significant competitive disadvantage and may disqualify submissions.
• Framework agreement compliance: Once admitted to a Sykehusinnkjøp HF framework agreement, suppliers must comply with framework pricing ceilings, delivery commitments, and reporting obligations throughout the agreement period (typically 2–4 years, with optional extension). Framework reporting is quarterly in most categories.

Market structure and opportunity

• Specialist healthcare concentration: Norway's specialist healthcare is entirely publicly funded through the four RHFs, with a minimal private specialist hospital market. This concentration makes Sykehusinnkjøp HF framework agreements extremely valuable — a single national framework agreement covers essentially the entire public specialist hospital market simultaneously.
• Primary and community care: Municipal-funded primary care (nursing homes, rehabilitation, community health centres) represents a secondary but growing procurement channel for home-care technology, diagnostic equipment, and assistive devices. Municipal procurement is decentralised across 356 municipalities and requires separate monitoring from the RHF system.
• Private hospitals: Private hospital chains (Aleris, Volvat, Colosseumklinikken, Capio) operate in elective surgery, rehabilitation, and specialist outpatient care. Their procurement follows internal company purchasing procedures without Doffin publication requirements, typically operating through negotiated contracts with preferred suppliers.
• Growth segments: Norway is investing in digital health integration, point-of-care diagnostics for rural and remote communities, minimally invasive surgical systems, and remote patient monitoring technology driven by geographic distribution challenges. The Norwegian government's health strategy prioritises technology-enabled home and community care, creating sustained procurement growth in these categories.
• Sovereign wealth fund effect: Norway's Government Pension Fund Global (oil fund) underpins a well-funded public healthcare system. Budget constraints are present but less severe than in most European markets, and Norwegian hospitals typically pay at or above EU-average prices for medical devices. Price sensitivity in Norwegian tenders is lower than in Southern European markets.

Common challenges for foreign suppliers

1. Framework agreement timing barrier: If your device category is covered by a current Sykehusinnkjøp HF framework agreement and you are not a party to it, individual hospital trusts generally cannot purchase your products without running their own separate tender. Understanding the framework renewal calendar — and positioning for the next framework tender — is the critical market entry variable. Framework agreements typically run 2–4 years; missing a framework window means potentially waiting the full term for the next competitive opportunity.
2. Norwegian-language documentation: Norwegian-language tender responses, product labels, and IFU are expected. For companies whose primary EU MDR documentation language is English or another EU language, Norwegian translation adds cost and lead time. German translations are not a substitute.
3. Local service infrastructure: Sykehusinnkjøp HF tenders consistently require demonstrated Norwegian service capacity. Suppliers who service Norway remotely from Central European service bases face competitive disadvantage against suppliers with Norwegian service engineers or established local service partnerships. Building or contracting local Norwegian service capacity is a prerequisite for framework admission in most device categories.
4. Reference site network: Norwegian hospital evaluation committees value Norwegian or Scandinavian reference installations. Building a reference site network requires market entry at the hospital trust level before Sykehusinnkjøp HF framework applications — which requires either individual hospital tender wins or demonstration projects with clinical departments.

Tips for foreign suppliers

1. Monitor Doffin proactively for framework renewals: Sykehusinnkjøp HF framework agreement renewal tenders are the highest-value opportunities in the Norwegian market. Set Doffin monitoring for your product category CPV codes and track Sykehusinnkjøp HF prior information notices, which often appear 6–12 months before the formal tender. The renewal schedule for each category is partially predictable from prior framework start dates. Orbid AI tracks Norwegian tender opportunities across Doffin, including Sykehusinnkjøp HF framework notices and hospital trust direct tenders. Book a demo to see Norwegian market coverage in action.
2. Build service infrastructure before bidding on frameworks: Norwegian service capacity is a qualification requirement, not a scoring criterion — absence of Norwegian service disqualifies submissions outright in many categories. Establish either a Norwegian service subsidiary or a documented partnership with a Norwegian service provider before submitting framework tender applications.
3. Leverage EU MDR investment: Norway's EEA membership means valid EU MDR CE marking provides Norwegian market access with no additional regulatory work. Your entire EU regulatory compliance investment — CE marking, Notified Body certificate, EUDAMED registration — is fully leveraged in Norway. Focus incremental investment on Norwegian labelling, Norwegian-language documentation, and EUDAMED compliance rather than any Norway-specific regulatory work.
4. Enter through hospital trust direct procurement: Before Sykehusinnkjøp HF framework admission is achievable, target individual hospital trust direct tenders for specialised or novel device categories not yet covered by national frameworks. Oslo University Hospital, Haukeland, and St. Olavs Hospital conduct direct tenders for advanced diagnostic and surgical equipment. A successful hospital trust reference provides the Scandinavian installation evidence needed for subsequent framework applications.
5. Attend Nordic medtech events: Sykehusinnkjøp HF procurement specialists and hospital trust procurement managers attend Nordic medtech events and international exhibitions. Clinical KOL relationships at Oslo University Hospital and Haukeland University Hospital are valuable for building the reference network and generating pull-through procurement demand that supports framework applications. For further context on regional procurement strategy, see our Sweden procurement guide and global healthcare tenders guide.